Variable | All (n = 117) | ICU survivors (n = 58) | ICU non-survivors (n = 59) | Statistics (p) |
---|---|---|---|---|
Heart: | ||||
LVEF, % | 51 ± 15 | 50 ± 15 | 52 ± 14 | 0.5 |
LVOT VTI | 18 ± 5 | 18 ± 5 | 19 ± 5 | 0.2 |
PASP, mmHg | 36.7 ± 12.9 | 32.5 ± 9.8 | 40.4 ± 14.3 | 0.024a |
TAPSE, cm | 1.95 ± 0.52 | 1.93 ± 0.56 | 1.97 ± 0.49 | 0.7 |
TAPSE/PASP, cm/mmHg | 0.05 ± 0.02 | 0.05 ± 0.02 | 0.05 ± 0.02 | 0.8 |
VCI min. diameter, cm | 1.6 ± 0.8 | 1.7 ± 0.7 | 1.5 ± 0.8 | 0.3 |
VCI max. diameter, cm | 2.1 ± 0.5 | 2.2 ± 0.5 | 2.0 ± 0.6 | 0.3 |
Lung: | ||||
Diffuse B-lines pattern, n (%) | 54 (46) | 19 (33) | 35 (59) | 0.005az |
Mixed A-/B-lines pattern, n (%) | 41 (35) | 24 (41) | 17 (29) | 0.3 |
A-lines pattern, n (%) | 3 (3) | 3 (5) | 0 | 0.2 |
Pleural effusion, n (%) | 16 (13) | 9 (16) | 7 (12) | 0.8 |
Lung consolidations, n (%) | 3 (3) | 3 (5) | 0 | 0.2 |